Sponsor:
Brooke Army Medical Center
Code:
NCT03406169
Conditions
Erectile Dysfunction
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 30 - 70+
Healthy Volunteers: Accepted
Interventions
Sildenafil 25 MG Oral Tablet
Pentoxifylline
Placebo
Brief summary:
Conditions
Erectile Dysfunction
Prostate Cancer
Study ID
NCT03406169
Start date
Feb 13, 2017
Status verified date
Jan, 2018
Completion date
Mar, 2022
Anticipated
Primary completion date
Dec, 2021
Anticipated
Eligibility Criteria
Sex: Male
Age: 30 - 70+
Healthy Volunteers: Accepted
Enrollment
180 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Treatment
Arms
active comparator: Sildenafil 25mg Oral Tablet
active comparator: Pentoxifylline
placebo comparator: Placebo
Interventions
Sildenafil 25 MG Oral Tablet
Pentoxifylline
Placebo
Primary outcome measure
Central contacts
Locations
Brooke Army Medical Center
Recruiting
San Antonio, Texas, United States, 78234
Contacts
Sponsor
Brooke Army Medical Center
Last update posted
Jan 23, 2018
Last verified
Jan, 2018
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-02. This information was provided to ClinicalTrials.gov by Brooke Army Medical Center on 2018-01-23. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.